NCT07113158View on ClinicalTrials.gov

Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

June 17, 2029

Study Completion Date

November 17, 2029

Conditions
Sudden Sensorineural Hearing Loss
Interventions
DRUG

Aspirin + Acid folic

Aspirin 100 mg/day and Acid Folic 5 mg/day + gold standard treatment

DRUG

Placebo Aspirin + Placebo Acid folic

The Placebo Aspirin 100 mg/j + Placebo folic acid 5 mg/j + reference treatment

Trial Locations (1)

75010

Lariboisière Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER